(Q53222689)

12 May 2018

title

Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning. (English)

1 reference

12 May 2018

1 reference

1 reference

Ronald T Brown

1

0 references

author name string

Amy Perwien

2

1 reference

12 May 2018

Douglas E Faries

3

1 reference

12 May 2018

Christopher J Kratochvil

4

1 reference

12 May 2018

Brigette S Vaughan

5

1 reference

12 May 2018

publication date

1 November 2006

1 reference

12 May 2018

published in

Clinical Pediatrics

1 reference

12 May 2018

volume

45

1 reference

12 May 2018

issue

9

1 reference

12 May 2018

page(s)

819-827

1 reference

12 May 2018

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0009922806294219

Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922806294219

The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922806294219

Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922806294219

Stimulant medication for the child with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922806294219

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922806294219

Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922806294219

21 January 2018

Identifiers

DOI

10.1177/0009922806294219

1 reference

12 May 2018

1 reference

12 May 2018